Moderna and the Korean National Institute for Bioprocessing Research and Training (K-NIBRT) at Yonsei University have signed an agreement to develop mRNA education content and programs, accelerating the full-scale operation of the curriculum.The agreement follows a memorandum of understanding signed
Medical AI company Lunit said Thursday that it would present seven research studies using its AI biomarker platform, “Lunit SCOPE,” at the 2024 American Society of Clinical Oncology (ASCO 2024) in Chicago, U.S., from May 31 to June 4.Lunit will present a poster on identifying HER2 Ultra-Low breast c
Celltrion's Remsima (infliximab) line of products continues to demonstrate market impact with expanded prescriptions in five major European countries—the U.K., Germany, France, Spain, and Italy—also known as EU5.According to pharmaceutical market research firm IQVIA, as of the fourth quarter of 2023
HK inno.N's GERD drug K-CAB has expanded its momentum to the Middle East and North Africa region.Starting from China and expanding across Asia and North and South America, K-CAB is increasing its global market dominance by advancing to the Middle East and North Africa markets, according to the compa
Boston Scientific said Monday that it has released the BIB System, a balloon for suppressing appetite in the stomach that can help obese patients lose weight, with insurance coverage in Korea. The BIB System is an intragastric appetite suppression balloon for weight loss treatment in patients with a
Plasmapp, a bioplasma deep-tech company, said Monday that it had signed a contract to supply plasma sterilizers to Osstem Implant.Following signing contracts with large global distributors of STERLINK lite plus (STERLINK U510 in overseas brand name) in the U.S. and Japan, Plasmapp successfully signe
Canon Medical Systems Korea said it installed Aquilion Exceed LB, a state-of-the-art low-dose radiation CT (computed tomography) simulation machine, at Yeungnam University Medical Center in Daegu. The latest CT simulation, to be operational from Monday, is the first AI-powered CT simulation in North
On Monday, EuBiologics announced that it obtained regulatory approval to initiate a phase 1 study for its proprietary herpes zoster vaccine, EuHZV. With the endorsement from the Ministry of Food and Drug Safety, the company's immune modulation technology has broadened its scope from addressing emerg
Celltrion said it has been awarded the national tender for the world's only infliximab subcutaneous (SC) formulation, Remsima SC, in Denmark, a key Nordic market. Under the agreement, Remsima SC will be supplied to Denmark for one year starting this month.Celltrion launched Remsima SC in Norway in F
Coreline Soft, a Korean medical AI company, said Thursday that the National Evidence-based Healthcare Collaborating Agency (NECA) has completed “notifying innovative medical technology use (clinical practice) results” for its AVIEW NeuroCAD, which was selected as an innovative medical technology.Acc
A "somatic symptom disorder" is a condition in which physical symptoms, including pain, fatigue, indigestion, or dizziness, persist without a clear cause.These symptoms can be very disruptive to daily life, but tests to find the cause often show no abnormalities. The focus on physical symptoms is a
The Ministry of Food and Drug Safety said on Tuesday that it banned foreign-made dietary supplements containing or made with prohibited ingredients that could cause side effects like impaired vision or arrhythmia. The regulator designated diphenhydramine, a type of antihistamine, and yellow oleander
EuBiologics said on Tuesday that its Euvichol-S, a simplified formulation of the oral cholera vaccine co-developed with the International Vaccine Institute (IVI), has obtained prequalification (PQ) certification from the World Health Organization (WHO).Euvichol-S is a new oral cholera vaccine that h
CHA Bundang Medical Center (CBMC) has signed an agreement with Rutgers University, a prestigious public university in the United States, for joint research and technology development.Rutgers University Executive Vice President for Academic Affairs Prabhas V. Moghe, Professor Lee Ki-bum of the Depart
Yuyu Pharma said its contract manufacturing organization (CMO) business, a new growth engine, is on a roll with a series of contract signings.This month, the company signed new CMO agreements with 10 pharmaceutical companies for manufacturing Fexogien Tab. (fexofenadine hydrochloride), an antihistam
AbbVie Korea's psoriatic disease treatment Skyrizi (risankizumab) won approval from the Ministry of Food and Drug Safety (MFDS) on Tuesday for treating moderate-to-severe pustular psoriasis of the hands and feet in adults (18 years and older) who have had an inadequate response to or are intolerant
GE HealthCare Korea said it has signed a business agreement with LG Electronics and Microsoft Korea to innovate the healthcare industry and develop and build smart hospitals.GE HealthCare Korea CEO Kim Yong-duk, Microsoft Korea CEO Cho Won-woo and LG Electronics Vice President for Business Solutions
Hugel, a total medical aesthetics company, said Tuesday that its polydioxanone (PDO) suture brand Licellvi (domestic product name: Blue Rose Forte) has received a product license from the Brazilian National Agency for Food and Drug Surveillance (ANVISA).Licellvi is a PDO suture brand of JWorld, a su
Pinotbio is increasing its competitiveness on the global stage by emphasizing effectiveness and safety by combining the “PBX-7 Series” and “sequential cleavage linker.”Pinotbio, an ADC platform company, said Monday that it unveiled preclinical results of its ADC platform at the American Association
Crystal Life Sciences said it changed its name to Huons Life Sciences and will continue its operations under the new name.The name changing decision was made at a recent extraordinary shareholders’ meeting.As a subsidiary of Huons, Huons Life Sciences will reorganize its portfolio in line with the v